Angela Walsh
CIK 1825987 · Chief Financial Officer · last filed 2026-03-06
Angela Walsh is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for DWTX, was dated Mar 6, 2026. Across all open-market trades the lifetime net is +$16.4K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
11
$16.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DWTX | Chief Financial Officer | — | $1.55 | — | $0 | 3 | 2026-03-06 |
| Dogwood Therapeutics, Inc. (VIRI) Delisted | SVP OF FINANCE | 120 | $3.88 | $465 | $16.4K | 8 | 2024-02-28 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-06 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2025-12-05 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2025-07-01 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2024-02-28 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-14 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-30 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-24 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Buy (P) | +2,000 | $9.2K | EDGAR |
| 2021-06-22 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-01 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Buy (P) | +1,000 | $7.3K | EDGAR |
| 2021-01-12 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.